2024 Q1 Form 10-K Financial Statement

#000106163024000029 Filed on February 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $486.1M $505.0M $2.038B
YoY Change -1.07% 9.24% 52.18%
Cost Of Revenue $362.7M $377.6M $1.486B
YoY Change 4.14% 23.79% 80.96%
Gross Profit $123.5M $127.4M $551.6M
YoY Change -13.74% -18.97% 6.53%
Gross Profit Margin 25.4% 25.23% 27.07%
Selling, General & Admin $12.25M $11.42M $43.92M
YoY Change 12.05% 4.13% -0.93%
% of Gross Profit 9.92% 8.96% 7.96%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $248.6M $13.25M $51.14M
YoY Change 1832.34% -8.54% -2.01%
Operating Profit -$125.1M $114.2M $500.4M
YoY Change -196.05% -20.03% 7.49%
Interest Expense $343.7M $1.400B
YoY Change 8.36% 96.93%
% of Operating Profit 279.76%
Other Income/Expense, Net
YoY Change
Pretax Income -$122.2M -$1.017M $255.3M
YoY Change -201.43% -97.79% 0.47%
Income Tax $1.002M $699.0K $5.400M
% Of Pretax Income 2.12%
Net Earnings -$123.8M -$2.377M $246.6M
YoY Change -205.16% -95.0% -0.84%
Net Earnings / Revenue -25.47% -0.47% 12.1%
Basic Earnings Per Share -$0.71 $1.43
Diluted Earnings Per Share -$0.71 -$0.01 $1.43
COMMON SHARES
Basic Shares Outstanding 173.7M shares 172.3M shares 172.7M shares
Diluted Shares Outstanding 174.0M shares 172.7M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $414.0M $350.0M $350.0M
YoY Change -19.74% 20.14% 20.14%
Cash & Equivalents $414.0M $350.0M $350.0M
Short-Term Investments
Other Short-Term Assets $115.5M $153.4M $153.4M
YoY Change 15.69% 120.6% 120.6%
Inventory
Prepaid Expenses
Receivables $206.2M $214.8M $214.8M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $735.7M $718.3M $718.3M
YoY Change -7.76% 30.49% 30.49%
LONG-TERM ASSETS
Property, Plant & Equipment $60.20M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $22.53B $23.32B $23.32B
YoY Change -8.37% -5.99% -5.99%
TOTAL ASSETS
Total Short-Term Assets $735.7M $718.3M $718.3M
Total Long-Term Assets $22.53B $23.32B $23.32B
Total Assets $23.27B $24.04B $24.04B
YoY Change -8.35% -5.2% -5.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.839M $7.265M $7.265M
YoY Change -20.37% -25.3% -25.3%
Accrued Expenses $105.6M $124.2M $124.2M
YoY Change 11.08% 8.83% 8.83%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $15.37M $15.37M
YoY Change -100.0% -6.16% -6.16%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $220.1M $254.2M $254.2M
YoY Change -2.7% 3.05% 3.05%
LONG-TERM LIABILITIES
Long-Term Debt $18.84B $19.29B $19.29B
YoY Change -8.27% -5.38% -5.38%
Other Long-Term Liabilities $37.87M $108.3M $108.3M
YoY Change -33.61% -39.89% -39.89%
Total Long-Term Liabilities $18.88B $19.39B $19.39B
YoY Change -8.34% -5.68% -5.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $220.1M $254.2M $254.2M
Total Long-Term Liabilities $18.88B $19.39B $19.39B
Total Liabilities $19.12B $19.65B $19.67B
YoY Change -8.18% -5.58% -5.6%
SHAREHOLDERS EQUITY
Retained Earnings -$1.383B -$1.151B
YoY Change 44.32% 18.81%
Common Stock $5.518B $5.509B
YoY Change 0.59% 0.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.145B $4.368B $4.368B
YoY Change
Total Liabilities & Shareholders Equity $23.27B $24.04B $24.04B
YoY Change -8.35% -5.2% -5.2%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$123.8M -$2.377M $246.6M
YoY Change -205.16% -95.0% -0.84%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $94.61M $109.8M $458.8M
YoY Change -14.13% -15.69% 15.63%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $376.3M $257.0M $1.444B
YoY Change 140.41% -580.66% -144.38%
Cash From Investing Activities $376.3M $257.0M $1.444B
YoY Change 140.41% -580.66% -144.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -404.3M -440.5M -$1.848B
YoY Change 824.74% 583.91% -170.88%
NET CHANGE
Cash From Operating Activities 94.61M 109.8M $458.8M
Cash From Investing Activities 376.3M 257.0M $1.444B
Cash From Financing Activities -404.3M -440.5M -$1.848B
Net Change In Cash 66.58M -73.71M $54.98M
YoY Change -70.14% -697.11% -122.04%
FREE CASH FLOW
Cash From Operating Activities $94.61M $109.8M $458.8M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.77
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170631410 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151521941 shares
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
255259000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
254060000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
422696000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
251057000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
422273000 usd
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3080000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
23787012000 usd
CY2023Q4 bxmt Financing Receivable Excluding Accrued Interest Net Loans Exposure Amount
FinancingReceivableExcludingAccruedInterestNetLoansExposureAmount
21951988000 usd
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
CY2023 us-gaap Oci Cash Flow Hedge Reclassification For Discontinuance Statement Of Income Or Comprehensive Income Extensible Enumeration
OciCashFlowHedgeReclassificationForDiscontinuanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#InterestExpense
CY2021 us-gaap Oci Cash Flow Hedge Reclassification For Discontinuance Statement Of Income Or Comprehensive Income Extensible Enumeration
OciCashFlowHedgeReclassificationForDiscontinuanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#InterestExpense
CY2022 us-gaap Oci Cash Flow Hedge Reclassification For Discontinuance Statement Of Income Or Comprehensive Income Extensible Enumeration
OciCashFlowHedgeReclassificationForDiscontinuanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#InterestExpense
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
3400000000 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
173674472 shares
CY2023 dei Auditor Firm
AuditorFirmId
34
CY2023 dei Auditor Name
AuditorName
Deloitte & Touche LLP
CY2023 dei Auditor Location
AuditorLocation
New York, New York
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
350014000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
291340000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
23787012000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
25017880000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
576936000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326137000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23210076000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24691743000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
476088000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
370902000 usd
CY2023Q4 us-gaap Assets
Assets
24036178000 usd
CY2022Q4 us-gaap Assets
Assets
25353985000 usd
CY2023Q4 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
12683095000 usd
CY2022Q4 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
13528164000 usd
CY2023Q4 bxmt Securitized Debt Obligations Net
SecuritizedDebtObligationsNet
2505417000 usd
CY2022Q4 bxmt Securitized Debt Obligations Net
SecuritizedDebtObligationsNet
2664010000 usd
CY2023Q4 bxmt Asset Specific Debt Agreements Net
AssetSpecificDebtAgreementsNet
1000210000 usd
CY2022Q4 bxmt Asset Specific Debt Agreements Net
AssetSpecificDebtAgreementsNet
942503000 usd
CY2023Q4 us-gaap Participating Mortgage Loans Participation Liabilities Amount
ParticipatingMortgageLoansParticipationLiabilitiesAmount
337179000 usd
CY2022Q4 us-gaap Participating Mortgage Loans Participation Liabilities Amount
ParticipatingMortgageLoansParticipationLiabilitiesAmount
224232000 usd
CY2023Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
2101632000 usd
CY2022Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
2114549000 usd
CY2023Q4 us-gaap Senior Notes
SeniorNotes
362763000 usd
CY2022Q4 us-gaap Senior Notes
SeniorNotes
395166000 usd
CY2023Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
295847000 usd
CY2022Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
514257000 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
362531000 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
426904000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
19648674000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
20809785000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
173209933 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
173209933 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
171695985 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
171695985 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1732000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1717000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5507459000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5475804000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9454000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
10022000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1150934000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-968749000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4367711000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4518794000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
19793000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
25406000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4387504000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4544200000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24036178000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25353985000 usd
CY2023 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
2037621000 usd
CY2022 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
1338954000 usd
CY2021 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
854690000 usd
CY2023 us-gaap Interest Expense
InterestExpense
1366956000 usd
CY2022 us-gaap Interest Expense
InterestExpense
710904000 usd
CY2021 us-gaap Interest Expense
InterestExpense
340223000 usd
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
670665000 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
628050000 usd
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
514467000 usd
CY2023 us-gaap Management Fee Expense
ManagementFeeExpense
119089000 usd
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
110292000 usd
CY2021 us-gaap Management Fee Expense
ManagementFeeExpense
88467000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
52193000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43168000 usd
CY2021 us-gaap Noninterest Expense
NoninterestExpense
131635000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5362000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3003000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
423000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
249897000 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3342000 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2415000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
246555000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
248642000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
419193000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.43
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.43
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.46
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.46
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.77
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
172672038 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172672038 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
170631410 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151521941 shares
CY2023 us-gaap Profit Loss
ProfitLoss
249897000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
251057000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
422273000 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
75339000 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-171652000 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-84470000 usd
CY2023 bxmt Other Comprehensive Income Realized And Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeRealizedAndUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-75907000 usd
CY2022 bxmt Other Comprehensive Income Realized And Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeRealizedAndUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
173366000 usd
CY2021 bxmt Other Comprehensive Income Realized And Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeRealizedAndUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
81608000 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-568000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1714000 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2862000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
249329000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
252771000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
419411000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3342000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2415000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3080000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
245987000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
250356000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
416331000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3904231000 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
638004000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
31052000 usd
CY2021 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
879000 usd
CY2021 bxmt Adjustments To Additional Paid In Capital Deferred Compensation
AdjustmentsToAdditionalPaidInCapitalDeferredCompensation
595000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
422273000 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2862000 usd
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.48
CY2021 us-gaap Dividends
Dividends
384741000 usd
CY2021 bxmt Cash Contributions From Joint Venture Partners That Increase Equity
CashContributionsFromJointVenturePartnersThatIncreaseEquity
55912000 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
70651000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
32724000 usd
CY2022 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
1176000 usd
CY2022 bxmt Adjustments To Additional Paid In Capital Deferred Compensation
AdjustmentsToAdditionalPaidInCapitalDeferredCompensation
690000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
251057000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1714000 usd
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.48
CY2022 us-gaap Dividends
Dividends
424513000 usd
CY2022 bxmt Cash Contributions From Joint Venture Partners That Increase Equity
CashContributionsFromJointVenturePartnersThatIncreaseEquity
5040000 usd
CY2022 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
12573000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4544200000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
29975000 usd
CY2023 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
1015000 usd
CY2023 bxmt Adjustments To Additional Paid In Capital Deferred Compensation
AdjustmentsToAdditionalPaidInCapitalDeferredCompensation
680000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
249897000 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-568000 usd
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.48
CY2023 us-gaap Dividends
Dividends
428740000 usd
CY2023 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
8955000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4387504000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
249897000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
251057000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
422273000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
30655000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
33414000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
31647000 usd
CY2023 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
78428000 usd
CY2022 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
81748000 usd
CY2021 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
68905000 usd
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
54264000 usd
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
50020000 usd
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
41002000 usd
CY2023 bxmt Payment In Kind Interest Net Of Interest Received
PaymentInKindInterestNetOfInterestReceived
2865000 usd
CY2022 bxmt Payment In Kind Interest Net Of Interest Received
PaymentInKindInterestNetOfInterestReceived
0 usd
CY2021 bxmt Payment In Kind Interest Net Of Interest Received
PaymentInKindInterestNetOfInterestReceived
0 usd
CY2023 bxmt Increase Decrease In Current Expected Credit Loss Reserve
IncreaseDecreaseInCurrentExpectedCreditLossReserve
249790000 usd
CY2022 bxmt Increase Decrease In Current Expected Credit Loss Reserve
IncreaseDecreaseInCurrentExpectedCreditLossReserve
211505000 usd
CY2021 bxmt Increase Decrease In Current Expected Credit Loss Reserve
IncreaseDecreaseInCurrentExpectedCreditLossReserve
-39864000 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
4616000 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023 us-gaap Difference Between Reported Amount And Reporting Currency Denominated Amount Value
DifferenceBetweenReportedAmountAndReportingCurrencyDenominatedAmountValue
0 usd
CY2022 us-gaap Difference Between Reported Amount And Reporting Currency Denominated Amount Value
DifferenceBetweenReportedAmountAndReportingCurrencyDenominatedAmountValue
-31000 usd
CY2021 us-gaap Difference Between Reported Amount And Reporting Currency Denominated Amount Value
DifferenceBetweenReportedAmountAndReportingCurrencyDenominatedAmountValue
-6866000 usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-2769000 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
4339000 usd
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3934000 usd
CY2023 bxmt Realized Gains Losses On Derivative Financial Instruments Net
RealizedGainsLossesOnDerivativeFinancialInstrumentsNet
28202000 usd
CY2022 bxmt Realized Gains Losses On Derivative Financial Instruments Net
RealizedGainsLossesOnDerivativeFinancialInstrumentsNet
15609000 usd
CY2021 bxmt Realized Gains Losses On Derivative Financial Instruments Net
RealizedGainsLossesOnDerivativeFinancialInstrumentsNet
-3890000 usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
20666000 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
106372000 usd
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
21616000 usd
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
6243000 usd
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
58928000 usd
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
24856000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
458841000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
396825000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
382483000 usd
CY2023 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
1344130000 usd
CY2022 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
6810218000 usd
CY2021 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
12550463000 usd
CY2023 us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
2840467000 usd
CY2022 us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
3254595000 usd
CY2021 us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
6730339000 usd
CY2023 us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
17992000 usd
CY2022 us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
74930000 usd
CY2021 us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
143002000 usd
CY2023 bxmt Payments For Derivative Instruments In Investing Activities
PaymentsForDerivativeInstrumentsInInvestingActivities
233544000 usd
CY2022 bxmt Payments For Derivative Instruments In Investing Activities
PaymentsForDerivativeInstrumentsInInvestingActivities
23057000 usd
CY2021 bxmt Payments For Derivative Instruments In Investing Activities
PaymentsForDerivativeInstrumentsInInvestingActivities
77772000 usd
CY2023 bxmt Proceeds From Derivative Instruments In Investing Activities
ProceedsFromDerivativeInstrumentsInInvestingActivities
163682000 usd
CY2022 bxmt Proceeds From Derivative Instruments In Investing Activities
ProceedsFromDerivativeInstrumentsInInvestingActivities
353325000 usd
CY2021 bxmt Proceeds From Derivative Instruments In Investing Activities
ProceedsFromDerivativeInstrumentsInInvestingActivities
76383000 usd
CY2023 bxmt Payments For Collateral Deposits Related To Derivatives
PaymentsForCollateralDepositsRelatedToDerivatives
352120000 usd
CY2022 bxmt Payments For Collateral Deposits Related To Derivatives
PaymentsForCollateralDepositsRelatedToDerivatives
217220000 usd
CY2021 bxmt Payments For Collateral Deposits Related To Derivatives
PaymentsForCollateralDepositsRelatedToDerivatives
109670000 usd
CY2023 bxmt Proceeds From Collateral Deposits Related To Derivatives
ProceedsFromCollateralDepositsRelatedToDerivatives
351730000 usd
CY2022 bxmt Proceeds From Collateral Deposits Related To Derivatives
ProceedsFromCollateralDepositsRelatedToDerivatives
114110000 usd
CY2021 bxmt Proceeds From Collateral Deposits Related To Derivatives
ProceedsFromCollateralDepositsRelatedToDerivatives
160720000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1444077000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3253535000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5627461000 usd
CY2023 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
1636899000 usd
CY2022 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
5282882000 usd
CY2021 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
12475664000 usd
CY2023 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
2742450000 usd
CY2022 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
3578806000 usd
CY2021 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
7801330000 usd
CY2023 bxmt Proceeds From Issuance Of Collateralized Loan Obligations
ProceedsFromIssuanceOfCollateralizedLoanObligations
0 usd
CY2022 bxmt Proceeds From Issuance Of Collateralized Loan Obligations
ProceedsFromIssuanceOfCollateralizedLoanObligations
0 usd
CY2021 bxmt Proceeds From Issuance Of Collateralized Loan Obligations
ProceedsFromIssuanceOfCollateralizedLoanObligations
803750000 usd
CY2023 bxmt Repayments For Collateralized Loan Obligations
RepaymentsForCollateralizedLoanObligations
166027000 usd
CY2022 bxmt Repayments For Collateralized Loan Obligations
RepaymentsForCollateralizedLoanObligations
182084000 usd
CY2021 bxmt Repayments For Collateralized Loan Obligations
RepaymentsForCollateralizedLoanObligations
888763000 usd
CY2023 bxmt Proceeds From Asset Specific Debt Agreements
ProceedsFromAssetSpecificDebtAgreements
292019000 usd
CY2022 bxmt Proceeds From Asset Specific Debt Agreements
ProceedsFromAssetSpecificDebtAgreements
770665000 usd
CY2021 bxmt Proceeds From Asset Specific Debt Agreements
ProceedsFromAssetSpecificDebtAgreements
272065000 usd
CY2023 bxmt Repayments Of Asset Specific Debt Agreements
RepaymentsOfAssetSpecificDebtAgreements
239037000 usd
CY2022 bxmt Repayments Of Asset Specific Debt Agreements
RepaymentsOfAssetSpecificDebtAgreements
208644000 usd
CY2021 bxmt Repayments Of Asset Specific Debt Agreements
RepaymentsOfAssetSpecificDebtAgreements
271065000 usd
CY2023 bxmt Proceeds From Sale Of Loan Participation
ProceedsFromSaleOfLoanParticipation
100692000 usd
CY2022 bxmt Proceeds From Sale Of Loan Participation
ProceedsFromSaleOfLoanParticipation
245278000 usd
CY2021 bxmt Proceeds From Sale Of Loan Participation
ProceedsFromSaleOfLoanParticipation
0 usd
CY2023 bxmt Proceeds From Issuance Of Secured Term Loan
ProceedsFromIssuanceOfSecuredTermLoan
0 usd
CY2022 bxmt Proceeds From Issuance Of Secured Term Loan
ProceedsFromIssuanceOfSecuredTermLoan
807750000 usd
CY2021 bxmt Proceeds From Issuance Of Secured Term Loan
ProceedsFromIssuanceOfSecuredTermLoan
298500000 usd
CY2023 bxmt Repayments Of Secured Term Loans
RepaymentsOfSecuredTermLoans
21997000 usd
CY2022 bxmt Repayments Of Secured Term Loans
RepaymentsOfSecuredTermLoans
17053000 usd
CY2021 bxmt Repayments Of Secured Term Loans
RepaymentsOfSecuredTermLoans
13495000 usd
CY2023 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 usd
CY2022 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 usd
CY2021 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
400000000 usd
CY2023 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
28945000 usd
CY2022 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 usd
CY2021 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
294000000 usd
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2023 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
220000000 usd
CY2022 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
402500000 usd
CY2021 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
45996000 usd
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
43725000 usd
CY2023 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 usd
CY2022 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
5040000 usd
CY2021 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
55912000 usd
CY2023 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
8955000 usd
CY2022 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
12573000 usd
CY2021 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
46632000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
70651000 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
638005000 usd
CY2023 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
426927000 usd
CY2022 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
421386000 usd
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
370662000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1847943000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2607224000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5508224000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
54975000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-249486000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
263246000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
291340000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
551154000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
289970000 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3699000 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-10328000 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2062000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
350014000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
291340000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
551154000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
1292958000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
608259000 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
287715000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6668000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
676000 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-73000 usd
CY2023 bxmt Dividends Declared And Not Paid
DividendsDeclaredAndNotPaid
107390000 usd
CY2022 bxmt Dividends Declared And Not Paid
DividendsDeclaredAndNotPaid
106455000 usd
CY2021 bxmt Dividends Declared And Not Paid
DividendsDeclaredAndNotPaid
104271000 usd
CY2023 bxmt Loan Principal Payments Held By Servicer
LoanPrincipalPaymentsHeldByServicer
48287000 usd
CY2022 bxmt Loan Principal Payments Held By Servicer
LoanPrincipalPaymentsHeldByServicer
7425000 usd
CY2021 bxmt Loan Principal Payments Held By Servicer
LoanPrincipalPaymentsHeldByServicer
17528000 usd
CY2023 us-gaap Nature Of Operations
NatureOfOperations
ORGANIZATION <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">References herein to “Blackstone Mortgage Trust,” “Company,” “we,” “us” or “our” refer to Blackstone Mortgage Trust, Inc., a Maryland corporation, and its subsidiaries unless the context specifically requires otherwise. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Blackstone Mortgage Trust is a real estate finance company that originates senior loans collateralized by commercial real estate in North America, Europe, and Australia. Our portfolio is composed primarily of loans secured by high-quality, institutional assets in major markets, sponsored by experienced, well-capitalized real estate investment owners and operators. These senior loans are capitalized by accessing a variety of financing options, including borrowing under our credit facilities, issuing CLOs or single-asset securitizations, and corporate financing, depending on our view of the most prudent financing option available for each of our investments. We are not in the business of buying or trading securities, and the only securities we own are the retained interests from our securitization financing transactions, which we have not financed. We are externally managed by BXMT Advisors L.L.C., or our Manager, a subsidiary of Blackstone Inc., or Blackstone, and are a real estate investment trust, or REIT, traded on the New York Stock Exchange, or NYSE, under the symbol “BXMT.” Our principal executive offices are located at 345 Park Avenue, 24th Floor, New York, New York 10154. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We conduct our operations as a REIT for U.S. federal income tax purposes. We generally will not be subject to U.S. federal income taxes on our taxable income to the extent that we annually distribute all of our net taxable income to stockholders and maintain our qualification as a REIT. We also operate our business in a manner that permits us to maintain an exclusion from registration under the Investment Company Act of 1940, as amended. We are organized as a holding company and conduct our business primarily through our various subsidiaries.</span></div>
CY2017Q4 bxmt Joint Venture Capital Contribution Percentage
JointVentureCapitalContributionPercentage
0.85
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Use of Estimates </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may ultimately differ materially from those estimates.</span></div>
CY2023 us-gaap Revenue Recognition Interest
RevenueRecognitionInterest
<div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenue Recognition </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Interest income from our loans receivable portfolio is recognized over the life of each investment using the effective interest method and is recorded on the accrual basis. Recognition of fees, premiums, and discounts associated with these investments is deferred and recorded over the term of the loan as an adjustment to yield. Income accrual is generally suspended for loans at the earlier of the date at which payments become 90 days past due or when, in our opinion, recovery of income and principal becomes doubtful. Interest received is then recorded as income or as a reduction in the amortized cost basis, based on the specific facts and circumstances, until accrual is resumed when the loan becomes contractually current and performance is demonstrated to be resumed. In addition, for loans we originate, the related origination expenses are deferred and recognized as a reduction to interest income, however expenses related to loans we acquire are included in general and administrative expenses as incurred.</span></div>
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2023Q4 us-gaap Escrow Deposit
EscrowDeposit
640600000 usd
CY2022Q4 us-gaap Escrow Deposit
EscrowDeposit
459600000 usd
CY2023 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
178 security_loan
CY2022 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
203 security_loan
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
23923719000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
25160343000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23210076000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24691743000 usd
CY2023 bxmt Mortgage Loan On Real Estate Final Maturity Term
MortgageLoanOnRealEstateFinalMaturityTerm
P2Y4M24D
CY2022 bxmt Mortgage Loan On Real Estate Final Maturity Term
MortgageLoanOnRealEstateFinalMaturityTerm
P3Y1M6D
CY2023Q4 bxmt Loans Receivable Percentage Of Loans By Principal Balance Fixed Rate
LoansReceivablePercentageOfLoansByPrincipalBalanceFixedRate
0.01
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
23923719000 usd
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
22156437000 usd
CY2021Q4 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
-153420000 usd
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
22003017000 usd
CY2022 bxmt Financing Receivable New Issue
FinancingReceivableNewIssue
6810218000 usd
CY2022 bxmt Financing Receivable New Issue
FinancingReceivableNewIssue
6810218000 usd
CY2022 bxmt Financing Receivable Sale And Collection Of Finance Receivables And Cost Recovery Proceeds
FinancingReceivableSaleAndCollectionOfFinanceReceivablesAndCostRecoveryProceeds
3168155000 usd
CY2022 bxmt Financing Receivable Sale And Collection Of Finance Receivables And Cost Recovery Proceeds
FinancingReceivableSaleAndCollectionOfFinanceReceivablesAndCostRecoveryProceeds
3168155000 usd
CY2022 bxmt Financing Receivable Gain Loss On Foreign Currency Translation
FinancingReceivableGainLossOnForeignCurrencyTranslation
-638157000 usd
CY2022 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Gain Loss On Foreign Currency Translation
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountGainLossOnForeignCurrencyTranslation
-5255000 usd
CY2022 bxmt Financing Receivable Before Allowance For Credit Loss Fee And Loan In Process Gain Loss On Foreign Currency Translation
FinancingReceivableBeforeAllowanceForCreditLossFeeAndLoanInProcessGainLossOnForeignCurrencyTranslation
-632902000 usd
CY2022 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount New Issues
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountNewIssues
74930000 usd
CY2022 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount New Issues
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountNewIssues
74930000 usd
CY2022 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Amortization
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountAmortization
80632000 usd
CY2022 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Amortization
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountAmortization
80632000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
25160343000 usd
CY2022Q4 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
-142463000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
25017880000 usd
CY2023 bxmt Financing Receivable New Issue
FinancingReceivableNewIssue
1344130000 usd
CY2023 bxmt Financing Receivable New Issue
FinancingReceivableNewIssue
1344130000 usd
CY2023 bxmt Financing Receivable Sale And Collection Of Finance Receivables And Cost Recovery Proceeds
FinancingReceivableSaleAndCollectionOfFinanceReceivablesAndCostRecoveryProceeds
2871423000 usd
CY2023 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Sale And Collection Of Finance Receivables And Cost Recovery Proceeds
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountSaleAndCollectionOfFinanceReceivablesAndCostRecoveryProceeds
52978000 usd
CY2023 bxmt Financing Receivable Before Allowance For Credit Loss Fee And Loan In Process Sale And Collection Of Finance Receivables And Cost Recovery Proceeds
FinancingReceivableBeforeAllowanceForCreditLossFeeAndLoanInProcessSaleAndCollectionOfFinanceReceivablesAndCostRecoveryProceeds
2924401000 usd
CY2023 bxmt Payment In Kind Interest Net Of Interest Received
PaymentInKindInterestNetOfInterestReceived
2865000 usd
CY2023 bxmt Payment In Kind Interest Net Of Interest Received
PaymentInKindInterestNetOfInterestReceived
2865000 usd
CY2023 bxmt Financing Receivable Gain Loss On Foreign Currency Translation
FinancingReceivableGainLossOnForeignCurrencyTranslation
287804000 usd
CY2023 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Gain Loss On Foreign Currency Translation
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountGainLossOnForeignCurrencyTranslation
1702000 usd
CY2023 bxmt Financing Receivable Before Allowance For Credit Loss Fee And Loan In Process Gain Loss On Foreign Currency Translation
FinancingReceivableBeforeAllowanceForCreditLossFeeAndLoanInProcessGainLossOnForeignCurrencyTranslation
286102000 usd
CY2023 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount New Issues
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountNewIssues
17992000 usd
CY2023 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount New Issues
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountNewIssues
17992000 usd
CY2023 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Amortization
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountAmortization
78428000 usd
CY2023 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Amortization
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountAmortization
78428000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
23923719000 usd
CY2023Q4 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
-136707000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
23787012000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
576936000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23210076000 usd
CY2023 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
178 loan
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
23787012000 usd
CY2023Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
24971028000 usd
CY2023Q4 bxmt Financing Receivable Excluding Accrued Interest Net Loans Exposure Amount
FinancingReceivableExcludingAccruedInterestNetLoansExposureAmount
21951988000 usd
CY2023Q4 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
576936000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23210076000 usd
CY2023 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
178 loan
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
23787012000 usd
CY2023Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
24971028000 usd
CY2023Q4 bxmt Financing Receivable Excluding Accrued Interest Net Loans Exposure Amount
FinancingReceivableExcludingAccruedInterestNetLoansExposureAmount
21951988000 usd
CY2023Q4 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
576936000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23210076000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
23900000000 usd
CY2023Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1100000000 usd
CY2023Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1100000000 usd
CY2023Q4 bxmt Net Loan Exposure Amount Asset Specific Debt
NetLoanExposureAmountAssetSpecificDebt
1000000000 usd
CY2023 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Sale And Collection Of Finance Receivables And Cost Recovery Proceeds
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountSaleAndCollectionOfFinanceReceivablesAndCostRecoveryProceeds
53000000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
576900000 usd
CY2022 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
203 loan
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
25017880000 usd
CY2022Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
26810281000 usd
CY2022Q4 bxmt Financing Receivable Excluding Accrued Interest Net Loans Exposure Amount
FinancingReceivableExcludingAccruedInterestNetLoansExposureAmount
23659183000 usd
CY2022Q4 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326137000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24691743000 usd
CY2022 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
203 loan
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
25017880000 usd
CY2022Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
26810281000 usd
CY2022Q4 bxmt Financing Receivable Excluding Accrued Interest Net Loans Exposure Amount
FinancingReceivableExcludingAccruedInterestNetLoansExposureAmount
23659183000 usd
CY2022Q4 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326137000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24691743000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
25200000000 usd
CY2022Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1600000000 usd
CY2022Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1600000000 usd
CY2022Q4 bxmt Net Loan Exposure Amount Asset Specific Debt
NetLoanExposureAmountAssetSpecificDebt
950300000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326100000 usd
CY2023 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
178 loan
CY2023Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
24971028000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
576936000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23210076000 usd
CY2022 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
203 loan
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
25017880000 usd
CY2022Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
26810281000 usd
CY2022Q4 bxmt Financing Receivable Excluding Accrued Interest Net Loans Exposure Amount
FinancingReceivableExcludingAccruedInterestNetLoansExposureAmount
23659183000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326137000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24691743000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
23900000000 usd
CY2023Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1100000000 usd
CY2023Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1100000000 usd
CY2023Q4 bxmt Net Loan Exposure Amount Asset Specific Debt
NetLoanExposureAmountAssetSpecificDebt
1000000000 usd
CY2023 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Sale And Collection Of Finance Receivables And Cost Recovery Proceeds
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountSaleAndCollectionOfFinanceReceivablesAndCostRecoveryProceeds
53000000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
576900000 usd
CY2022Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1600000000 usd
CY2022Q4 bxmt Net Loan Exposure Amount Asset Specific Debt
NetLoanExposureAmountAssetSpecificDebt
950300000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326100000 usd
CY2023Q4 bxmt Weighted Average Risk Rating
WeightedAverageRiskRating
3.0
CY2022Q4 bxmt Weighted Average Risk Rating
WeightedAverageRiskRating
2.9
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326137000 usd
CY2023 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
250799000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
576936000 usd
CY2022 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
201458000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326137000 usd
CY2023 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
250800000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
576900000 usd
CY2023 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
53000000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
576936000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23210076000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326137000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24691743000 usd
CY2023 bxmt Financing Receivable Modified Number Of Contracts
FinancingReceivableModifiedNumberOfContracts
5 loan
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
214835000 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
189569000 usd
CY2023Q4 bxmt Loan Portfolio Payments Held By Our Third Party Loan Servicer
LoanPortfolioPaymentsHeldByOurThirdPartyLoanServicer
152423000 usd
CY2022Q4 bxmt Loan Portfolio Payments Held By Our Third Party Loan Servicer
LoanPortfolioPaymentsHeldByOurThirdPartyLoanServicer
68489000 usd
CY2023Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
103500000 usd
CY2022Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
103110000 usd
CY2023Q4 bxmt Accounts Receivable Net Current And Other Assets Current
AccountsReceivableNetCurrentAndOtherAssetsCurrent
2420000 usd
CY2022Q4 bxmt Accounts Receivable Net Current And Other Assets Current
AccountsReceivableNetCurrentAndOtherAssetsCurrent
1318000 usd
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
1890000 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
7349000 usd
CY2023Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
1020000 usd
CY2022Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
1067000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
476088000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
370902000 usd
CY2023Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
107390000 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
106455000 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
97820000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
80263000 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
94817000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
119665000 usd
CY2023Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
15371000 usd
CY2022Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
16380000 usd
CY2023Q4 bxmt Secured Debt Repayments Pending Servicer Remittance
SecuredDebtRepaymentsPendingServicerRemittance
13526000 usd
CY2022Q4 bxmt Secured Debt Repayments Pending Servicer Remittance
SecuredDebtRepaymentsPendingServicerRemittance
60585000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
7265000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
9726000 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
362531000 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
426904000 usd
CY2023Q4 bxmt Debt Instrument Covenant Requirement On Consolidated Tangible Net Worth Minimum
DebtInstrumentCovenantRequirementOnConsolidatedTangibleNetWorthMinimum
3600000000 usd
CY2023Q4 bxmt Debt Instrument Covenant Maximum Percentage Of Cash Liquidity On Recourse Indebtedness
DebtInstrumentCovenantMaximumPercentageOfCashLiquidityOnRecourseIndebtedness
0.05
CY2023 bxmt Interest Expense Secured Debt
InterestExpenseSecuredDebt
171400000 usd
CY2022 bxmt Interest Expense Secured Debt
InterestExpenseSecuredDebt
87600000 usd
CY2023Q4 us-gaap Share Price
SharePrice
21.27
CY2023Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
103500000 usd
CY2023 us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
317000 usd
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
1890000 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
7349000 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
94817000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
119665000 usd
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-75014000 usd
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
173362000 usd
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
81598000 usd
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
893000 usd
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
-4000 usd
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
-10000 usd
CY2023 us-gaap Interest Expense
InterestExpense
1400000000 usd
CY2022 us-gaap Interest Expense
InterestExpense
710900000 usd
CY2021 us-gaap Interest Expense
InterestExpense
340200000 usd
CY2022Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
103100000 usd
CY2023Q4 bxmt Stock Shares Authorized
StockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
172106593 shares
CY2021Q4 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
168543370 shares
CY2020Q4 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
147086722 shares
CY2023 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6587 shares
CY2022 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2311711 shares
CY2023 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
1402329 shares
CY2023 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
53888 shares
CY2022 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
47036 shares
CY2021 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
56881 shares
CY2023Q4 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
173569397 shares
CY2022Q4 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
172106593 shares
CY2021Q4 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
168543370 shares
CY2023Q4 bxmt Deferred Stock Units
DeferredStockUnits
359464 shares
CY2022Q4 bxmt Deferred Stock Units
DeferredStockUnits
410608 shares
CY2021Q4 bxmt Deferred Stock Units
DeferredStockUnits
363572 shares
CY2023 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
6587 shares
CY2022 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
8242 shares
CY2023 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
6587 shares
CY2022 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
8242 shares
CY2021 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
2184 shares
CY2023Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.62
CY2023Q4 us-gaap Dividends
Dividends
107400000 usd
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.48
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.48
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.48
CY2023 bxmt Class A Common Stock Dividends Declared
ClassACommonStockDividendsDeclared
1.0000
CY2022 bxmt Class A Common Stock Dividends Declared
ClassACommonStockDividendsDeclared
1.0000
CY2021 bxmt Class A Common Stock Dividends Declared
ClassACommonStockDividendsDeclared
1.0000
CY2023 bxmt Direct Stock Units Dividends Declared
DirectStockUnitsDividendsDeclared
0
CY2022 bxmt Direct Stock Units Dividends Declared
DirectStockUnitsDividendsDeclared
0
CY2021 bxmt Direct Stock Units Dividends Declared
DirectStockUnitsDividendsDeclared
0
CY2023 bxmt Common Stock Dividends Declared
CommonStockDividendsDeclared
1.0000
CY2022 bxmt Common Stock Dividends Declared
CommonStockDividendsDeclared
1.0000
CY2021 bxmt Common Stock Dividends Declared
CommonStockDividendsDeclared
1.0000
CY2023 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
878000 usd
CY2022 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
945000 usd
CY2021 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
812000 usd
CY2023 us-gaap Dividends
Dividends
428740000 usd
CY2022 us-gaap Dividends
Dividends
424513000 usd
CY2021 us-gaap Dividends
Dividends
384741000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
246555000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
248642000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
419193000 usd
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
172672038 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172672038 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170631410 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
170631410 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151521941 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.43
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.43
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.46
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.46
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.77
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.77
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9500000 usd
CY2023Q4 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
183900000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-174400000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
10000000 usd
CY2022Q4 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
259800000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-249800000 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
13269000 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
10924000 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
7759000 usd
CY2023 bxmt General And Administrative Operating And Other Costs
GeneralAndAdministrativeOperatingAndOtherCosts
7219000 usd
CY2022 bxmt General And Administrative Operating And Other Costs
GeneralAndAdministrativeOperatingAndOtherCosts
7855000 usd
CY2021 bxmt General And Administrative Operating And Other Costs
GeneralAndAdministrativeOperatingAndOtherCosts
3762000 usd
CY2023 bxmt Core General And Administrative Expenses
CoreGeneralAndAdministrativeExpenses
20488000 usd
CY2022 bxmt Core General And Administrative Expenses
CoreGeneralAndAdministrativeExpenses
18779000 usd
CY2021 bxmt Core General And Administrative Expenses
CoreGeneralAndAdministrativeExpenses
11521000 usd
CY2023 us-gaap Restricted Stock Expense
RestrictedStockExpense
29975000 usd
CY2022 us-gaap Restricted Stock Expense
RestrictedStockExpense
32724000 usd
CY2021 us-gaap Restricted Stock Expense
RestrictedStockExpense
31052000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
680000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
690000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
595000 usd
CY2023 bxmt Non Cash And Legacy Compensation Expenses
NonCashAndLegacyCompensationExpenses
30655000 usd
CY2022 bxmt Non Cash And Legacy Compensation Expenses
NonCashAndLegacyCompensationExpenses
33414000 usd
CY2021 bxmt Non Cash And Legacy Compensation Expenses
NonCashAndLegacyCompensationExpenses
31647000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51143000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
52193000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43168000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5400000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000000.0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
423000 usd
CY2013Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
25875000 shares
CY2023Q4 bxmt Operating Loss Carryforwards Limitations On Use Annual Limitation
OperatingLossCarryforwardsLimitationsOnUseAnnualLimitation
2000000.0 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
159000000.0 usd
CY2023Q4 bxmt Number Of Current Benefit Plans
NumberOfCurrentBenefitPlans
2 plan
CY2023Q4 bxmt Number Of Benefit Plans
NumberOfBenefitPlans
9 plan
CY2023Q4 bxmt Number Of Expired Benefit Plans
NumberOfExpiredBenefitPlans
7 plan
CY2023Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
350014000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
291340000 usd
CY2023Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
23923719000 usd
CY2022Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
25160343000 usd
CY2023Q4 bxmt Securitized Debt Obligations Net Face Amount
SecuritizedDebtObligationsNetFaceAmount
2507514000 usd
CY2022Q4 bxmt Securitized Debt Obligations Net Face Amount
SecuritizedDebtObligationsNetFaceAmount
2673541000 usd
CY2023Q4 bxmt Asset Specific Debt Gross
AssetSpecificDebtGross
1004097000 usd
CY2022Q4 bxmt Asset Specific Debt Gross
AssetSpecificDebtGross
950278000 usd
CY2023Q4 bxmt Participating Mortgage Loans Participation Liabilities Principal Amount
ParticipatingMortgageLoansParticipationLiabilitiesPrincipalAmount
337721000 usd
CY2022Q4 bxmt Participating Mortgage Loans Participation Liabilities Principal Amount
ParticipatingMortgageLoansParticipationLiabilitiesPrincipalAmount
224744000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2467573000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2425664000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
5601381000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
3827957000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
508361000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
1671530000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
16502466000 usd
CY2023 bxmt Debt Instrument Amortization Percentage
DebtInstrumentAmortizationPercentage
0.010
CY2023Q4 bxmt Securitized Debt Obligations Excluded From Contractual Obligations
SecuritizedDebtObligationsExcludedFromContractualObligations
2500000000 usd
CY2023Q4 bxmt Nonconsolidated Securitized Debt Excluded From Contractual Obligations
NonconsolidatedSecuritizedDebtExcludedFromContractualObligations
1100000000 usd
CY2023Q4 bxmt Net Loan Exposure Amount Loan Participations Sold
NetLoanExposureAmountLoanParticipationsSold
337700000 usd
CY2023 bxmt Board Of Directors Number Of Members
BoardOfDirectorsNumberOfMembers
10 director
CY2023 bxmt Number Of Directors Eligible For Annual Compensation
NumberOfDirectorsEligibleForAnnualCompensation
6 director
CY2023 bxmt Number Of Directors Not Eligible For Compensation
NumberOfDirectorsNotEligibleForCompensation
4 director
CY2023Q4 srt Mortgage Loans On Real Estate Prior Liens1
MortgageLoansOnRealEstatePriorLiens1
1148233000 usd
CY2023Q4 srt Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
23923719000 usd
CY2023Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
23787012000 usd
CY2023Q4 srt Mortgage Loans On Real Estate Principal Amount Of Delinquent Loans
MortgageLoansOnRealEstatePrincipalAmountOfDelinquentLoans
140000000 usd
CY2023Q4 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
576936000 usd
CY2023Q4 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Net
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateNet
23210076000 usd
CY2023Q4 srt Mortgage Loans On Real Estate Federal Income Tax Basis1
MortgageLoansOnRealEstateFederalIncomeTaxBasis1
23500000000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
576900000 usd
CY2022Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
25017880000 usd
CY2021Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
22003017000 usd
CY2020Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
16572715000 usd
CY2023 us-gaap Mortgage Loans On Real Estate New Mortgage Loans
MortgageLoansOnRealEstateNewMortgageLoans
1344130000 usd
CY2022 us-gaap Mortgage Loans On Real Estate New Mortgage Loans
MortgageLoansOnRealEstateNewMortgageLoans
6810218000 usd
CY2021 us-gaap Mortgage Loans On Real Estate New Mortgage Loans
MortgageLoansOnRealEstateNewMortgageLoans
12550463000 usd
CY2023 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Payment In Kind Interest Net Of Interest Received
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstatePaymentInKindInterestNetOfInterestReceived
2865000 usd
CY2022 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Payment In Kind Interest Net Of Interest Received
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstatePaymentInKindInterestNetOfInterestReceived
0 usd
CY2021 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Payment In Kind Interest Net Of Interest Received
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstatePaymentInKindInterestNetOfInterestReceived
0 usd
CY2023 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Amortization Of Fees And Other Items
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateAmortizationOfFeesAndOtherItems
78428000 usd
CY2022 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Amortization Of Fees And Other Items
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateAmortizationOfFeesAndOtherItems
80632000 usd
CY2021 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Amortization Of Fees And Other Items
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateAmortizationOfFeesAndOtherItems
68267000 usd
CY2023 srt Mortgage Loans On Real Estate Collections Of Principal
MortgageLoansOnRealEstateCollectionsOfPrincipal
2924401000 usd
CY2022 srt Mortgage Loans On Real Estate Collections Of Principal
MortgageLoansOnRealEstateCollectionsOfPrincipal
3168155000 usd
CY2021 srt Mortgage Loans On Real Estate Collections Of Principal
MortgageLoansOnRealEstateCollectionsOfPrincipal
6733105000 usd
CY2023 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Write Off
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateWriteOff
0 usd
CY2022 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Write Off
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateWriteOff
0 usd
CY2021 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Write Off
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateWriteOff
14427000 usd
CY2023 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Foreign Currency Translation
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateForeignCurrencyTranslation
286102000 usd
CY2022 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Foreign Currency Translation
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateForeignCurrencyTranslation
-632902000 usd
CY2021 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Foreign Currency Translation
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateForeignCurrencyTranslation
-297894000 usd
CY2023 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Deferred Fees And Other
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateDeferredFeesAndOther
17992000 usd
CY2022 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Deferred Fees And Other
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateDeferredFeesAndOther
74930000 usd
CY2021 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Deferred Fees And Other
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateDeferredFeesAndOther
143002000 usd
CY2023Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
23787012000 usd
CY2022Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
25017880000 usd
CY2021Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
22003017000 usd
CY2023Q4 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
576936000 usd
CY2022Q4 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
326137000 usd
CY2021Q4 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
124679000 usd
CY2023Q4 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Net
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateNet
23210076000 usd
CY2022Q4 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Net
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateNet
24691743000 usd
CY2021Q4 bxmt Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Net
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateNet
21878338000 usd

Files In Submission

Name View Source Status
0001061630-24-000029-index-headers.html Edgar Link pending
0001061630-24-000029-index.html Edgar Link pending
0001061630-24-000029.txt Edgar Link pending
0001061630-24-000029-xbrl.zip Edgar Link pending
bxmt-20231231.htm Edgar Link pending
bxmt-20231231.xsd Edgar Link pending
bxmt-20231231_g1.gif Edgar Link pending
bxmt-20231231_g2.jpg Edgar Link pending
bxmt-20231231_g3.jpg Edgar Link pending
bxmt-20231231_g4.jpg Edgar Link pending
bxmt-20231231_g5.jpg Edgar Link pending
exhibit1011.htm Edgar Link pending
exhibit1064.htm Edgar Link pending
exhibit211.htm Edgar Link pending
exhibit231.htm Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
exhibit322.htm Edgar Link pending
exhibit971.htm Edgar Link pending
exhibit991.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
bxmt-20231231_cal.xml Edgar Link unprocessable
bxmt-20231231_def.xml Edgar Link unprocessable
bxmt-20231231_lab.xml Edgar Link unprocessable
bxmt-20231231_pre.xml Edgar Link unprocessable
bxmt-20231231_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable